TANAKA CAPITAL MANAGEMENT INC

Position in NUVB — Nuvation Bio Inc.

CIK 816788 NEW YORK, NY

Position in NUVB

as of Mar 31, 2026 · filed May 18, 2026 Compact

Position Value

$3,868,829

-$3,671,951 QoQ

Shares Held

901,825

+7.2% QoQ

Ownership

0.257%

of shares outstanding

% of Portfolio

8.02%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2025

3 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

TANAKA CAPITAL MANAGEMENT INC holds $8,380,478 across 4 Biotechnology names. NUVB ranks #2 (46.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	CORT	Corcept Therapeutics Inc	110,854	$4,468,524
2	NUVB	Nuvation Bio Inc. This page	901,825	$3,868,829
3	BYSI	BeyondSpring Inc.	26,296	$43,125
4	CPRX	Catalyst Pharmaceuticals, Inc.	113,418	$0

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$3,868,829	901,825	+7.2%	Shares	Sole	2026-05-18
2025-12-31	$7,540,780	841,605	+22.8%	Shares	Sole	2026-02-17
2025-09-30	$2,534,888	685,105	—	Shares	Sole	2025-11-14
No filing history on record for this holder in this stock.